Oxford BioDynamics (LON:OBD) Hits New 52-Week Low – Should You Sell?

Oxford BioDynamics Plc (LON:OBD)’s share price reached a new 52-week low on Monday . The company traded as low as GBX 0.47 ($0.01) and last traded at GBX 0.51 ($0.01), with a volume of 33242113 shares trading hands. The stock had previously closed at GBX 0.53 ($0.01).

Oxford BioDynamics Price Performance

The stock has a fifty day simple moving average of GBX 0.95 and a 200-day simple moving average of GBX 2.76. The company has a market capitalization of £1.59 million, a PE ratio of -8.50 and a beta of 0.42. The company has a current ratio of 0.68, a quick ratio of 2.80 and a debt-to-equity ratio of 370.22.

About Oxford BioDynamics

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.